Mechanism of Action: Vasopressin V2 Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Vasopressin V2 Receptor Antagonists
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkem Labs Ltd | TOLVAPTAN | tolvaptan | TABLET;ORAL | 211891-001 | May 19, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Alkem Labs Ltd | TOLVAPTAN | tolvaptan | TABLET;ORAL | 211891-002 | May 19, 2020 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Msn | TOLVAPTAN | tolvaptan | TABLET;ORAL | 216949-002 | Jun 21, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |